This study aimed to evaluate the frequency of the CTNNB1 p.T41A mutation in ctDNA and tumor samples from HCC patients and to evaluate the concordance rates between plasma and tissue. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.